Integrated Diagnostics (OTCMKTS:IDGXF) Shares Down 14.2% – Time to Sell?

Integrated Diagnostics Holdings plc (OTCMKTS:IDGXFGet Free Report)’s share price was down 14.2% during mid-day trading on Monday . The stock traded as low as $0.4947 and last traded at $0.4947. 3,000 shares were traded during mid-day trading, an increase of 200% from the average daily volume of 1,000 shares. The stock had previously closed at $0.5764.

Integrated Diagnostics Stock Performance

The company has a fifty day moving average price of $0.60 and a two-hundred day moving average price of $0.64.

About Integrated Diagnostics

(Get Free Report)

Integrated Diagnostics Holdings PSC (OTCMKTS: IDGXF) is a leading provider of diagnostic services in the United Arab Emirates and the broader Gulf Cooperation Council (GCC) region. Headquartered in Abu Dhabi, the company operates an extensive network of pathology laboratories and radiology facilities, offering a comprehensive suite of clinical testing and medical imaging services. Its offerings span routine laboratory tests, advanced molecular diagnostics, histopathology, and a range of radiological modalities such as MRI, CT, ultrasound, and X-ray.

Since its founding in 1993, Integrated Diagnostics has expanded its footprint across the UAE, with patient service centers and lab collection points in Abu Dhabi, Dubai, and the Northern Emirates.

Featured Stories

Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.